Supernus Pharmaceuticals (SUPN)

Add to Watchlists Create an Alert
6.65 +0.05  +0.76%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

Supernus Pharmaceuticals Free Cash Flow:

-16.34M for Dec. 31, 2012
View Full Chart

Supernus Pharmaceuticals Free Cash Flow Chart

    Supernus Pharmaceuticals Historical Free Cash Flow Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -16.34M
    Sept. 30, 2012 -11.70M
    June 30, 2012 -9.809M
    March 31, 2012 -10.11M
       
    Dec. 31, 2011 -8.449M
    Sept. 30, 2011 -9.18M
    June 30, 2011 -9.237M
    March 31, 2011 -10.00M

    About Free Cash Flow

    Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

    According to many investors, free cash flow is the best indication of a company's ability to generate cash.
    Learn More

    Get data for

    SUPN Free Cash Flow Benchmarks

    Companies
    Pernix Therapeutics 4.754M
    Catalyst Pharmaceutical Partners -1.639M
    Lannett Company 6.744M

    SUPN Free Cash Flow Rankings

    Overall 53rd percentile
    3750 of 8009
    Sector 30th percentile
    479 of 687 in Healthcare
    Industry 28th percentile
    49 of 69 in Drug Manufacturers - Specialty & Generic

    SUPN Free Cash Flow Range, Past 5 Years

    Minimum -16.34M Dec 2012
    Maximum -8.449M Dec 2011
    Average -10.60M